Jim Simons's position in Cytokinetics is currently worth $2.57 Million. That's 0.00% of their equity portfolio (1750th largest holding). The first Cytokinetics trade was made in Q4 2013. Since then Jim Simons bought shares fifteen more times and sold shares on nine occasions. The stake costed the investor $1.3 Million, netting the investor a gain of 97% so far.